Collaborate Disseminate
Contraceptives like the pill may be effective, but messing with hormones has a range of unpleasant side effects. Now researchers are experimenting with a new non-hormonal contraceptive based on antibodies, which stops sperm swimming through mucus.Conti… Continue reading Non-hormonal contraceptive supercharges antibodies against sperm
A clinical trial run by the National Institutes of Health exploring the efficacy of convalescent plasma in treating mild to moderate COVID-19 patients has been halted. The once-promising treatment was deemed unlikely to be of any benefit and follows on… Continue reading US COVID-19 blood plasma trial halted by NIH
Promising interim data from a unique Phase 3 trial testing the efficacy of a monoclonal antibody cocktail developed to prevent SARS-CoV-2 infection has been announced by pharmaceutical company Regeneron. The preliminary results suggest this novel treat… Continue reading Monoclonal antibodies may prevent severe COVID-19, but there’s a catch
Pharmaceutical company Eli Lilly has announced its experimental antibody treatment can reduce a person’s risk of contracting COVID-19 by up to 80 percent. These preliminary results, from an ongoing Phase 3 trial, suggest the treatment may be an effecti… Continue reading Positive early data from large Phase 3 COVID-19 antibody trial
Early findings from a large international clinical trial suggest severely ill COVID-19 patients do not benefit from an experimental therapy involving infusions of blood plasma from those who have recovered from the disease. This particular arm of the s… Continue reading COVID-19 blood plasma therapy ineffective in severely ill patients
New research, led by a team from UC San Francisco, has shown how immune cells produced in the gut play a protective role during multiple sclerosis (MS) flare-ups. For the first time, scientists have shown how these immune cells travel up to the brain a… Continue reading New evidence of gut-brain mechanism involved in MS flare-ups
The U.S. Food and Drug Administration (FDA) has just approved the first coronavirus-specific antibody treatment for moderate cases of COVID-19. The focused Emergency Use Authorization (EUA) is aimed at newly diagnosed infections at the highest risk of … Continue reading FDA grants emergency approval to experimental COVID-19 antibody therapy
A new study, published in the prestigious journal Nature, is describing the surprising discovery of a previously unknown gut-brain link. The research reveals certain immune cells that inhabit a protective membrane surrounding the brain actually origina… Continue reading Immune cells discovered protecting the brain are trained in the gut
UK researchers are suggesting levels of antibodies produced by the immune system in response to SARS-CoV-2 may significantly drop in the months following an initial infection. Testing hundreds of thousands of subjects over three months, a study saw the… Continue reading Massive UK study finds coronavirus antibodies wane over several months
On October 8th 2020, Donald Trump returned to the White House after spending several days at the Walter Reed Medical Center receiving a number of treatments for COVID-19. In a video message published on Twitter the President attributed his rapid recove… Continue reading What do we know about Trump’s experimental COVID-19 “cure”?